Legacy Capital Group California’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-8,495
Closed -$412K 348
2024
Q2
$412K Buy
8,495
+384
+5% +$18.5K 0.15% 193
2024
Q1
$394K Buy
8,111
+4
+0% +$195 0.15% 192
2023
Q4
$403K Buy
+8,107
New +$396K 0.16% 189

Other funds holding SNY

Legacy Capital Group California's SNY Position: Q3 2024 in Review

Legacy Capital Group California sold out of Sanofi (SNY) in Q3 2024, closing a stake of 8,495 shares — an estimated $412K sold.

Legacy Capital Group California first reported a position in SNY in Q4 2023 and held it in 3 quarters. The position peaked at $412K in Q2 2024. 756 funds tracked by Wall St. Rank hold SNY as of Q3 2024.

  • Legacy Capital Group California reported no remaining Sanofi position as of Q3 2024 after selling out during the quarter.
  • Legacy Capital Group California sold 8,495 Sanofi shares in Q3 2024, an estimated $412K.
  • Legacy Capital Group California first reported a position in Sanofi in Q4 2023 and held it in 3 quarters.
  • Legacy Capital Group California's Sanofi position peaked at $412K in Q2 2024.
  • 756 funds tracked by Wall St. Rank held Sanofi as of Q3 2024.

Based on Legacy Capital Group California's 13F filing for Q3 2024, filed 23 Oct 2024.